ICD-10 category · Morphology of neoplasms · M998
M998 Myelodysplastic syndromes
22 codes under M998 in the South African Master Industry Table 2021, 16 valid for clinical use.
| Code | Description | Use | Benefits |
|---|---|---|---|
| M9980/1 | Refractory anaemia NOS, uncertain whether benign or malignant (D46.4)Discontinued in South Africa from 31 May 2013 | Discontinued | — |
| M9980/3 | Refractory anaemia, malignant, primary site | Valid · not as primary | — |
| M9980/6 | Refractory anaemia, malignant, metastatic site | Valid · not as primary | — |
| M9981/1 | Refractory anaemia without sideroblasts, uncertain whether benign or malignant (D46.0)Discontinued in South Africa from 31 May 2013 | Discontinued | — |
| M9982/1 | Refractory anaemia with sideroblasts, uncertain whether benign or malignant (D46.1)Discontinued in South Africa from 31 May 2013 | Discontinued | — |
| M9982/3 | Refractory anaemia with sideroblasts, malignant, primary site (D46.1) | Valid · not as primary | — |
| M9982/6 | Refractory anaemia with sideroblasts, malignant, metastatic site | Valid · not as primary | — |
| M9983/1 | Refractory anaemia with excess of blasts, uncertain whether benign or malignant (D46.2)Discontinued in South Africa from 31 May 2013 | Discontinued | — |
| M9983/3 | Refractory anaemia with excess blasts, malignant, primary site | Valid · not as primary | — |
| M9983/6 | Refractory anaemia with excess blasts, malignant, metastatic site | Valid · not as primary | — |
| M9984/1 | Refractory anaemia with excess of blasts with transformation, uncertain whether benign or malignant (D46.3)Discontinued in South Africa from 31 May 2013 | Discontinued | — |
| M9984/3 | Refractory anaemia with excess blasts in transformation, malignant, primary site | Valid · not as primary | — |
| M9984/6 | Refractory anaemia with excess blasts in transformation, malignant, metastatic site | Valid · not as primary | — |
| M9985/3 | Refractory cytopenia with multilineage dysplasia, malignant, primary site | Valid · not as primary | — |
| M9985/6 | Refractory cytopenia with multilineage dysplasia, malignant, metastatic site | Valid · not as primary | — |
| M9986/3 | Myelodysplastic syndrome with 5q deletion (5q-) syndrome, malignant, primary site | Valid · not as primary | — |
| M9986/6 | Myelodysplastic syndrome with 5q deletion (5q-) syndrome, malignant, metastatic site | Valid · not as primary | — |
| M9987/3 | Therapy-related myelodysplastic syndrome, NOS, malignant, primary site | Valid · not as primary | — |
| M9987/6 | Therapy-related myelodysplastic syndrome, NOS, malignant, metastatic site | Valid · not as primary | — |
| M9989/1 | Myelodysplastic syndrome NOS, uncertain whether benign or malignant (D46.9)Discontinued in South Africa from 31 May 2013 | Discontinued | — |
| M9989/3 | Myelodysplastic syndrome, NOS, malignant, primary site | Valid · not as primary | — |
| M9989/6 | Myelodysplastic syndrome, NOS, malignant, metastatic site | Valid · not as primary | — |
Source and terms
Reproduced from the national table, unaltered.
The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page
Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.
ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.
Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.
Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.
In GreenNotes
Code the consultation once. The invoice and the claim pick it up.
GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.